Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Letter

Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response

Bas Kreike1,2 email and Marc J van de Vijver3 email

Division of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

Division of Experimental Therapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

Division of Diagnostic Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands

author email corresponding author email

Breast Cancer Research 2007, 9:405doi:10.1186/bcr1832

Published: 17 December 2007


See related letter by Rakha et al., http://breast-cancer-research.com/content/9/6/404, and related research article by Kreike et al., http://breast-cancer-research.com/content/9/5/R65

First paragraph (this article has no abstract)

We read with interest the issues raised by Rakha and colleagues [1] in their response to our recent research article [2], and we are pleased to address them. An important conclusion from our research article is that triple-negative breast cancer can be equated to basal-like breast cancer. In their letter, Rakha and colleagues [1] state that equating triple-negative phenotype (TNP) tumours with basal-like breast cancer is misleading and is not supported by the data we have presented.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.